The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market was valued at US$ 3 million in 2023 and is anticipated to reach US$ 2 million by 2030, witnessing a CAGR of -2.8% during the forecast period 2024-2030.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
Report Scope
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Octreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market was valued at US$ 3 million in 2023 and is anticipated to reach US$ 2 million by 2030, witnessing a CAGR of -2.8% during the forecast period 2024-2030.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Octreotide.
Report Scope
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Octreotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Octreotide Market Overview
1.1 Product Overview and Scope of Octreotide
1.2 Octreotide Segment by Type
1.2.1 Global Octreotide Market Value Comparison by Type (2024-2030)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Octreotide Segment by Application
1.3.1 Global Octreotide Market Value by Application: (2024-2030)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Global Octreotide Market Size Estimates and Forecasts
1.4.1 Global Octreotide Revenue 2019-2030
1.4.2 Global Octreotide Sales 2019-2030
1.4.3 Global Octreotide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Octreotide Market Competition by Manufacturers
2.1 Global Octreotide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Octreotide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Octreotide Average Price by Manufacturers (2019-2024)
2.4 Global Octreotide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Octreotide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Octreotide, Product Type & Application
2.7 Octreotide Market Competitive Situation and Trends
2.7.1 Octreotide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Octreotide Players Market Share by Revenue
2.7.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Octreotide Retrospective Market Scenario by Region
3.1 Global Octreotide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Octreotide Global Octreotide Sales by Region: 2019-2030
3.2.1 Global Octreotide Sales by Region: 2019-2024
3.2.2 Global Octreotide Sales by Region: 2025-2030
3.3 Global Octreotide Global Octreotide Revenue by Region: 2019-2030
3.3.1 Global Octreotide Revenue by Region: 2019-2024
3.3.2 Global Octreotide Revenue by Region: 2025-2030
3.4 North America Octreotide Market Facts & Figures by Country
3.4.1 North America Octreotide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Octreotide Sales by Country (2019-2030)
3.4.3 North America Octreotide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Octreotide Market Facts & Figures by Country
3.5.1 Europe Octreotide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Octreotide Sales by Country (2019-2030)
3.5.3 Europe Octreotide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Octreotide Market Facts & Figures by Country
3.6.1 Asia Pacific Octreotide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Octreotide Sales by Country (2019-2030)
3.6.3 Asia Pacific Octreotide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Octreotide Market Facts & Figures by Country
3.7.1 Latin America Octreotide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Octreotide Sales by Country (2019-2030)
3.7.3 Latin America Octreotide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Octreotide Market Facts & Figures by Country
3.8.1 Middle East and Africa Octreotide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Octreotide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Octreotide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Octreotide Sales by Type (2019-2030)
4.1.1 Global Octreotide Sales by Type (2019-2024)
4.1.2 Global Octreotide Sales by Type (2025-2030)
4.1.3 Global Octreotide Sales Market Share by Type (2019-2030)
4.2 Global Octreotide Revenue by Type (2019-2030)
4.2.1 Global Octreotide Revenue by Type (2019-2024)
4.2.2 Global Octreotide Revenue by Type (2025-2030)
4.2.3 Global Octreotide Revenue Market Share by Type (2019-2030)
4.3 Global Octreotide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Octreotide Sales by Application (2019-2030)
5.1.1 Global Octreotide Sales by Application (2019-2024)
5.1.2 Global Octreotide Sales by Application (2025-2030)
5.1.3 Global Octreotide Sales Market Share by Application (2019-2030)
5.2 Global Octreotide Revenue by Application (2019-2030)
5.2.1 Global Octreotide Revenue by Application (2019-2024)
5.2.2 Global Octreotide Revenue by Application (2025-2030)
5.2.3 Global Octreotide Revenue Market Share by Application (2019-2030)
5.3 Global Octreotide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Octreotide Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Octreotide Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Chengdu Tiantaishan pharmaceutical Corporation Information
6.3.2 Chengdu Tiantaishan pharmaceutical Description and Business Overview
6.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
6.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
6.4 Sinopharm A-Think Pharmaceuticals
6.4.1 Sinopharm A-Think Pharmaceuticals Corporation Information
6.4.2 Sinopharm A-Think Pharmaceuticals Description and Business Overview
6.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
6.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments/Updates
6.5 Sihuan Pharmaceutical Holdings Group
6.5.1 Sihuan Pharmaceutical Holdings Group Corporation Information
6.5.2 Sihuan Pharmaceutical Holdings Group Description and Business Overview
6.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
6.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments/Updates
6.6 Shanghai Soho-Yiming Pharmaceuticals
6.6.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
6.6.2 Shanghai Soho-Yiming Pharmaceuticals Description and Business Overview
6.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
6.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments/Updates
6.7 Yibin Pharmaceutical
6.6.1 Yibin Pharmaceutical Corporation Information
6.6.2 Yibin Pharmaceutical Description and Business Overview
6.6.3 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yibin Pharmaceutical Octreotide Product Portfolio
6.7.5 Yibin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Octreotide Industry Chain Analysis
7.2 Octreotide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Octreotide Production Mode & Process
7.4 Octreotide Sales and Marketing
7.4.1 Octreotide Sales Channels
7.4.2 Octreotide Distributors
7.5 Octreotide Customers
8 Octreotide Market Dynamics
8.1 Octreotide Industry Trends
8.2 Octreotide Market Drivers
8.3 Octreotide Market Challenges
8.4 Octreotide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
